Detalhe da pesquisa
1.
Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial.
Lancet Oncol
; 25(2): 184-197, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38211606
2.
Tumoral PD-1hiCD8+ T cells are partially exhausted and predict favorable outcome in triple-negative breast cancer.
Clin Sci (Lond)
; 134(7): 711-726, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32202617
3.
Factors associated with upstaging in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Cancer Biol Med
; 16(2): 312-318, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31516751
4.
Phosphorylated eIF2α predicts disease-free survival in triple-negative breast cancer patients.
Sci Rep
; 7: 44674, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28294178
5.
Current status of breast reconstruction in China: an experience of 951 breast reconstructions from a single institute.
Gland Surg
; 5(3): 278-86, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27294034